세계의 레드 바이오테크놀러지 시장 - 산업 규모, 점유율, 동향, 경쟁, 기회, 예측 : 제품 유형별, 용도별, 최종 사용자별, 지역별, 경쟁별(2020-2030년)
Red Biotechnology Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, Segmented By Product Type, By Application, By End-User, By Region and Competition, 2020-2030F
상품코드:1743731
리서치사:TechSci Research
발행일:2025년 06월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 레드 바이오테크놀러지 시장은 2024년 4,213억 2,000만 달러로 평가되었고, 2030년에는 7,741억 5,000만 달러에 달하며, 예측 기간 동안 CAGR은 10.67%를 나타낼 것으로 전망됩니다.
시장 개척의 원동력이 되고 있는 것은 유전자 공학의 진보, 생명을 위협하는 질환을 타겟으로 한 신규 치료제에의 요구의 높아짐, 정밀의료 개발의 급증입니다. 치료 및 진단 용도를 위한 생체세포 및 생체분자 프로세스의 사용이 포함됩니다. 맞춤형 치료와 질병 특이적 치료 수요가 계속 확대되고 있는 가운데, 레드 바이오테크놀러지 부문은 선진국 시장과 신흥국 시장의 양쪽에서 큰 성장을 이루는 위치에 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모(2024년)
4,213억 2,000만 달러
시장 규모(2030년)
7,741억 5,000만 달러
CAGR(2025-2030년)
10.67%
급성장 부문
유전자 변형 의약품
최대 시장
북미
시장 성장 촉진요인
만성 및 희귀질환 관리에서 바이오 의약품 수요 증가
주요 시장 과제
높은 개발 비용과 복잡한 규제 요건
주요 시장 동향
맞춤형 의료 및 유전체학 기반 치료 확대
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 레드 바이오테크놀러지 시장 전망
시장 규모 및 예측
금액별
시장 점유율 및 예측
제품 유형(진단 시약, 인체 백신, 혈액 제제, 유전자 재조합 의약품 등)
용도별(바이오의약품 제조, 유전자 치료, 유전자 검사, 약물유전체학, 신약 개발 등)
최종 사용자별(제약 및 바이오테크놀러지 기업, CMO·CRO, 조사 기관 등)
기업별(2024년)
지역별
시장 맵
제6장 아시아태평양의 레드 바이오테크놀러지 시장 전망
시장 규모 및 예측
시장 점유율 및 예측
아시아태평양 : 국가별 분석
중국.
인도.
한국
일본
호주
제7장 유럽의 레드 바이오테크놀러지 시장 전망
시장 규모 및 예측
시장 점유율 및 예측
유럽 : 국가별 분석
프랑스
독일
영국
이탈리아
스페인
제8장 북미의 레드 바이오테크놀러지 시장 전망
시장 규모 및 예측
시장 점유율 및 예측
북미 : 국가별 분석
미국
멕시코
캐나다
제9장 남미의 레드 바이오테크놀러지 시장 전망
시장 규모 및 예측
시장 점유율 및 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 레드 바이오테크놀러지 시장 전망
시장 규모 및 예측
시장 점유율 및 예측
중동 및 아프리카 : 국가별 분석
남아프리카
사우디아라비아
아랍에미리트(UAE)
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
최근 동향
합병과 인수
제품 개발
제13장 Porter's Five Forces 분석
업계 내 경쟁
신규 진입의 가능성
공급자의 협상력
고객의 협상력
대체품의 위협/서비스
제14장 세계의 레드 바이오테크놀러지 시장 : SWOT 분석
제15장 경쟁 구도
Pfizer, Inc.
Takeda Pharmaceutical Company Limited
Gilead Sciences
Regeneron Pharmaceuticals, Inc.
F. Hoffmann-La Roche Ltd.
Bruker Corporation
Merck KGaA
Celgene Corporation
Amgen Inc.
Biogen Inc.
제16장 전략적 제안
제17장 기업 소개와 면책사항
KTH
영문 목차
영문목차
The Global Red Biotechnology Market was valued at USD 421.32 billion in 2024 and is projected to reach USD 774.15 billion by 2030, growing at a CAGR of 10.67% during the forecast period. Market growth is being driven by increasing advancements in genetic engineering, the growing need for novel therapeutics targeting life-threatening diseases, and the surge in precision medicine development. Red biotechnology involves the use of living cells and biomolecular processes for therapeutic and diagnostic applications, including the production of vaccines, gene therapies, diagnostic reagents, and biopharmaceuticals. As demand for personalized treatments and disease-specific therapies continues to expand, the red biotechnology sector is positioned for significant growth across both developed and emerging markets.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 421.32 Billion
Market Size 2030
USD 774.15 Billion
CAGR 2025-2030
10.67%
Fastest Growing Segment
Gene Recombinant Drugs
Largest Market
North America
Key Market Drivers
Rising Demand for Biopharmaceuticals in Chronic and Rare Disease Management
The increasing prevalence of chronic and rare diseases is a major factor accelerating the demand for red biotechnology, especially in the development of biopharmaceuticals such as recombinant proteins, monoclonal antibodies, and gene therapies. These innovations are addressing unmet medical needs where traditional treatments fall short. According to the World Health Organization (WHO), chronic illnesses-including cancer, cardiovascular diseases, diabetes, and respiratory disorders-account for approximately 74% of all global deaths. In parallel, rare diseases impact over 300 million individuals worldwide. Red biotechnology plays a vital role in the development of precision therapies for these complex health conditions, driving investment and research in this field globally.
Key Market Challenges
High Development Costs and Complex Regulatory Requirements
A major challenge in the red biotechnology market is the substantial cost and complexity associated with developing advanced therapeutics such as gene therapies and biologics. The R&D process involves extensive clinical trials, strict regulatory compliance, and rigorous quality controls, often resulting in long timelines and high expenses. According to the U.S. Congressional Budget Office (CBO), the cost of developing a single biopharmaceutical product can exceed $2.6 billion, and innovations within red biotechnology frequently surpass this due to their technical intricacies. Regulatory bodies such as the FDA and EMA impose detailed requirements for safety, efficacy, and long-term monitoring, particularly for gene-editing therapies. The variability in regulatory frameworks across different countries adds further challenges to global product launches, impacting speed to market and operational efficiency.
Key Market Trends
Expansion of Personalized Medicine and Genomics-Based Therapies
A transformative trend in the red biotechnology market is the rapid advancement of personalized medicine and genomics-driven therapies. Personalized medicine involves tailoring treatments to individual patients based on genetic, environmental, and lifestyle factors. Red biotechnology is central to this trend through the development of targeted therapies, gene-editing tools, and molecular diagnostics. The widespread adoption of next-generation sequencing (NGS) and genomic profiling has enabled deeper understanding of disease mechanisms, supporting the creation of patient-specific treatment plans. The declining cost of genome sequencing-from nearly $100 million in 2001 to under $1,000 in 2024-has accelerated clinical integration of genomics, propelling growth in red biotechnology applications.
Key Market Players
Pfizer, Inc.
Takeda Pharmaceutical Company Limited
Gilead Sciences
Regeneron Pharmaceuticals, Inc.
F. Hoffmann-La Roche Ltd.
Bruker Corporation
Merck KGaA
Celgene Corporation
Amgen Inc.
Biogen Inc.
Report Scope:
In this report, the Global Red Biotechnology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Red Biotechnology Market, By Product Type:
Diagnostic Reagents
Human Vaccines
Blood Products
Gene Recombinant Drugs
Others
Red Biotechnology Market, By Application:
Biopharmaceutical Production
Gene Therapy
Genetic Testing
Pharmacogenomics
Drug Discovery
Others
Red Biotechnology Market, By End-User:
Pharmaceutical and Biotechnology Companies
CMO & CRO
Research Institute
Others
Red Biotechnology Market, By Region:
North America
United States
Mexico
Canada
Europe
France
Germany
United Kingdom
Italy
Spain
Asia-Pacific
China
India
South Korea
Japan
Australia
South America
Brazil
Argentina
Colombia
Middle East and Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Red Biotechnology Market.
Available Customizations:
Global Red Biotechnology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered.
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Red Biotechnology Market Outlook.
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Diagnostic Reagents, Human Vaccines, Blood Products, Gene Recombinant Drugs and Others)
5.2.2. By Application (Biopharmaceutical Production, Gene Therapy, Genetic Testing, Pharmacogenomics, Drug Discovery, and Others)
5.2.3. By End-User (Pharmaceutical and Biotechnology companies, CMO & CRO, Research Institute and Others)
5.2.4. By Company (2024)
5.2.5. By Region
5.3. Market Map
6. Asia-Pacific Red Biotechnology Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By Application
6.2.3. By End-User
6.2.4. By Country
6.3. Asia-Pacific: Country Analysis
6.3.1. China Red Biotechnology Market Outlook.
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product Type
6.3.1.2.2. By Application
6.3.1.2.3. By End-User
6.3.2. India Red Biotechnology Market Outlook.
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product Type
6.3.2.2.2. By Application
6.3.2.2.3. By End-User
6.3.3. South Korea Red Biotechnology Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product Type
6.3.3.2.2. By Application
6.3.3.2.3. By End-User
6.3.4. Japan Red Biotechnology Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Product Type
6.3.4.2.2. By Application
6.3.4.2.3. By End-User
6.3.5. Australia Red Biotechnology Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Product Type
6.3.5.2.2. By Application
6.3.5.2.3. By End-User
7. Europe Red Biotechnology Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Application
7.2.3. By End-User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Red Biotechnology Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Type
7.3.1.2.2. By Application
7.3.1.2.3. By End-User
7.3.2. Germany Red Biotechnology Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Type
7.3.2.2.2. By Application
7.3.2.2.3. By End-User
7.3.3. United Kingdom Red Biotechnology Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Type
7.3.3.2.2. By Application
7.3.3.2.3. By End-User
7.3.4. Italy Red Biotechnology Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product Type
7.3.4.2.2. By Application
7.3.4.2.3. By End-User
7.3.5. Spain Red Biotechnology Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product Type
7.3.5.2.2. By Application
7.3.5.2.3. By End-User
8. North America Red Biotechnology Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Application
8.2.3. By End-User
8.2.4. By Country
8.3. North America: Country Analysis
8.3.1. United States Red Biotechnology Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Type
8.3.1.2.2. By Application
8.3.1.2.3. By End-User
8.3.2. Mexico Red Biotechnology Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Type
8.3.2.2.2. By Application
8.3.2.2.3. By End-User
8.3.3. Canada Red Biotechnology Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Type
8.3.3.2.2. By Application
8.3.3.2.3. By End-User
9. South America Red Biotechnology Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Application
9.2.3. By End-User
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Red Biotechnology Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Type
9.3.1.2.2. By Application
9.3.1.2.3. By End-User
9.3.2. Argentina Red Biotechnology Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Type
9.3.2.2.2. By Application
9.3.2.2.3. By End-User
9.3.3. Colombia Red Biotechnology Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Type
9.3.3.2.2. By Application
9.3.3.2.3. By End-User
10. Middle East and Africa Red Biotechnology Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Type
10.2.2. By Application
10.2.3. By End-User
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Red Biotechnology Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Type
10.3.1.2.2. By Application
10.3.1.2.3. By End-User
10.3.2. Saudi Arabia Red Biotechnology Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Type
10.3.2.2.2. By Application
10.3.2.2.3. By End-User
10.3.3. UAE Red Biotechnology Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product Type
10.3.3.2.2. By Application
10.3.3.2.3. By End-User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Mergers & Acquisitions
12.3. Product Developments
13. Porters Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products/Services
14. Global Red Biotechnology Market: SWOT Analysis
